Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $579,896 - $727,232
800 New
800 $724,000
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $1.05 Million - $1.24 Million
-2,000 Reduced 66.67%
1,000 $582,000
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $434,700 - $599,300
1,000 Added 50.0%
3,000 $1.61 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $701,480 - $937,960
2,000 New
2,000 $937,000
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $2.09 Million - $2.44 Million
-6,500 Reduced 25.79%
18,700 $6.84 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $177,888 - $202,722
-600 Reduced 2.33%
25,200 $8.15 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $5.77 Million - $6.77 Million
20,700 Added 405.88%
25,800 $8.36 Million
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $258,159 - $320,826
1,100 Added 27.5%
5,100 $1.46 Million
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $3.6 Million - $4.46 Million
-16,000 Reduced 80.0%
4,000 $1.11 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $5.45 Million - $6.71 Million
-24,600 Reduced 55.16%
20,000 $4.62 Million
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $8.05 Million - $10.4 Million
44,600 New
44,600 $10.2 Million
Q3 2020

Nov 16, 2020

SELL
$146.22 - $169.13 $1.46 Million - $1.69 Million
-10,000 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $286,482 - $344,778
2,100 Added 26.58%
10,000 $1.64 Million
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $19.7 Million - $24.5 Million
-184,700 Reduced 95.9%
7,900 $1.04 Million
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $21.4 Million - $25.2 Million
192,600 New
192,600 $25 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.